Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biopharmaceuticals derived from genetically modified plants.

D A Goldstein1, J A Thomas

  • 1Monsanto Company A2NE, 800 N. Lindbergh Blvd, St Louis, MO 63167, USA. daniel.a.goldstein@monsanto.com

QJM : Monthly Journal of the Association of Physicians
|October 22, 2004
PubMed
Summary

Plants are increasingly engineered to produce therapeutic proteins, addressing limitations in current biopharmaceutical production. This technology offers a promising, efficient, and scalable approach for developing new medicines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing cost-effectiveness considerations in the adoption of new drugs in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Improving access to immunotherapy in low- and middle-income countries.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Detection of Cross-Correlation between Gravitational Lensing and γ Rays.

Physical review letters·2020
Same author

Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Physical review letters·2019
Same author

Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.

Bone marrow transplantation·2016

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmacology

Background:

  • Modern biotechnology enables the use of plants for producing novel therapeutic agents.
  • There are nearly 500 biotechnology products approved or in development globally, highlighting production capacity limitations.
  • Efficient therapeutic protein production is crucial for meeting global demand.

Purpose of the Study:

  • To explore the potential of plants as a production system for biopharmaceuticals.
  • To discuss the selection of host plants and gene expression systems for efficient production.
  • To address safety and regulatory considerations for plant-based biopharmaceutical production.

Main Methods:

  • Genetic engineering of plants to express pharmacologically active proteins.

Related Experiment Videos

  • Selection of appropriate host plant species (food vs. non-food crops).
  • Evaluation of gene expression systems for optimal protein production.

    • Main Results:

    • Plants can be engineered to produce a wide range of therapeutic proteins, including antibodies, vaccines, and hormones.
    • Efficient production requires careful selection of host plants and expression systems.
    • Successful implementation necessitates addressing safety and regulatory frameworks.

    Conclusions:

    • Plant-based production of pharmaceuticals holds significant potential for the biopharmaceutical industry.
    • This approach offers an efficient and scalable method for producing various therapeutic agents.
    • Careful consideration of host selection, expression systems, safety, and regulation is vital for commercial viability.